ProQR Therapeutics (PRQR) Dividends Paid - Common (2013 - 2025)

ProQR Therapeutics has reported Dividends Paid - Common for 13 years, with the latest figure at $125.0 million in Q3 2025.

• Quarterly Dividends Paid - Common rose 27.27% year-over-year to $125.0 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $447.5 million (up 9.79% YoY) and the FY2021 annual result came in at $221.9 million, up 156.28% from the prior year.
• Dividends Paid - Common fell to $125.0 million in Q3 2025 per PRQR's latest filing, from $139.3 million in the prior quarter.
• Over five years, Dividends Paid - Common peaked at $214.5 million in Q4 2021 and troughed at $81.9 million in Q1 2021.
• A 5-year average of $137.7 million and a median of $139.3 million in 2025 frame the typical range for Dividends Paid - Common.
• The sharpest annual moves came in 2021 and 2022: Dividends Paid - Common jumped 75532.96% in 2021, then slumped 45.01% in 2022.
• Over 5 years, Dividends Paid - Common stood at $214.5 million in 2021, then slumped by 52.8% to $101.3 million in 2022, then climbed by 29.6% to $131.2 million in 2023, then decreased by 25.18% to $98.2 million in 2024, then advanced by 27.27% to $125.0 million in 2025.
• According to Business Quant data, Dividends Paid - Common over the past three periods registered $125.0 million, $139.3 million, and $98.2 million for Q3 2025, Q1 2025, and Q3 2024 respectively.